protegrin-1 and indolicidin

protegrin-1 has been researched along with indolicidin* in 2 studies

Other Studies

2 other study(ies) available for protegrin-1 and indolicidin

Article	Year
Susceptibility of human and murine Chlamydia trachomatis serovars to granulocyte- and epithelium-derived antimicrobial peptides. The journal of peptide research : official journal of the American Peptide Society, 2003, Volume: 61, Issue:5 Four antimicrobial peptides, protegrin-1, RTD-1, cryptdin-4, and indolicidin, were tested for their ability to inhibit the in vitro growth of Chlamydia trachomatis serovars E, L2, and mouse pneumonitis (MoPn). In general, protegrin-1 was found to have the strongest anti-chlamydial activity. Overall, of the three serovars tested, L2 was the most susceptible while MoPn was the most resistant to these peptides. Topics: alpha-Defensins; Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Chlamydia trachomatis; Defensins; Dose-Response Relationship, Drug; Epithelial Cells; Granulocytes; Humans; Mice; Peptides; Peptides, Cyclic; Proteins; Rabbits	2003
Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:5 A single animal can express several cationic antimicrobial peptides with different sequences and structures. We demonstrate that mammalian peptides from different structural classes frequently show synergy with each other and selectively show synergy with human lysozyme. Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Drug Synergism; Escherichia coli; Humans; Microbial Sensitivity Tests; Muramidase; Peptides; Peptides, Cyclic; Proteins; Pseudomonas aeruginosa; Staphylococcus aureus	2001

Article

Year

Susceptibility of human and murine Chlamydia trachomatis serovars to granulocyte- and epithelium-derived antimicrobial peptides.

The journal of peptide research : official journal of the American Peptide Society, 2003, Volume: 61, Issue:5

Four antimicrobial peptides, protegrin-1, RTD-1, cryptdin-4, and indolicidin, were tested for their ability to inhibit the in vitro growth of Chlamydia trachomatis serovars E, L2, and mouse pneumonitis (MoPn). In general, protegrin-1 was found to have the strongest anti-chlamydial activity. Overall, of the three serovars tested, L2 was the most susceptible while MoPn was the most resistant to these peptides.

Topics: alpha-Defensins; Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Chlamydia trachomatis; Defensins; Dose-Response Relationship, Drug; Epithelial Cells; Granulocytes; Humans; Mice; Peptides; Peptides, Cyclic; Proteins; Rabbits

2003

Synergistic interactions between mammalian antimicrobial defense peptides.

Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:5

A single animal can express several cationic antimicrobial peptides with different sequences and structures. We demonstrate that mammalian peptides from different structural classes frequently show synergy with each other and selectively show synergy with human lysozyme.

Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Drug Synergism; Escherichia coli; Humans; Microbial Sensitivity Tests; Muramidase; Peptides; Peptides, Cyclic; Proteins; Pseudomonas aeruginosa; Staphylococcus aureus

2001